Radiation before surgery for high-risk Ewing sarcoma
Part of Bones, joints & muscles, Cancer clinical trials.
This trial tests whether giving radiation therapy before surgery helps people with high-risk Ewing sarcoma. The goal is to make surgery more effective and possibly improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 55 years old or younger.
- You have been diagnosed with Ewing sarcoma, and tests show a specific genetic change (FET family gene rearrangement).
- Doctors believe it will be hard to remove the tumor completely with surgery alone.
- You are generally able to take care of yourself (ECOG performance status 0-1).
- You have not had radiation therapy to the tumor area before.
- You have not had another cancer in the past 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug, KC1036, for adolescents with advanced Ewing sarcoma that has not responded to other treatments. It aims to see if the drug can help shrink tumors or slow the cancer.
This trial tests a personalized radiation therapy that adjusts the dose based on your tumor. It aims to improve treatment for Ewing sarcoma while limiting side effects.
This trial tests a combination of radiation therapy and two drugs (anlotinib and penpulimab) given before surgery for soft tissue sarcoma. The goal is to see if this approach can shrink tumors and improve outcomes.
This trial tests giving a shorter, lower-dose radiation treatment before surgery for a retroperitoneal (deep belly/back space) soft-tissue sarcoma. The goal is to shrink or control the tumor and make surgery more effective and safe.
This is an observational study that follows people with Ewing’s sarcoma of the bone and certain “Ewing-like” tumors. It helps doctors understand the extent of disease at diagnosis and track outcomes, which may guide better planning for future care.
This trial tests a new type of radiation called spatially fractionated radiation therapy (SFRT) given before surgery for large soft tissue sarcomas in the arm, leg, or trunk. The goal is to see if it helps shrink the tumor and improve treatment outcomes.
Hear when a new Ewing Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.